Global Antiretroviral Drugs Market to Register 4.7% CAGR Through 2023

July 28, 2020


According to the research report titled ‘Global Antiretroviral Drugs Market: Analysis By Drug Type, By Region, By Country, Drug Forecast (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Europe, APAC, ROW), By Country available with Market Study Report LLC, global antiretroviral drugs market is expected to expand substantially, registering a CAGR of 4.7% over 2018-2023.
 

As per the findings of the report, growing occurrences of HIV AIDS, increased accessibility to novel medications with improved efficiency, and rising coverage rate of antiretroviral treatment are propelling the growth of global antiretroviral drugs market. Moreover, increasing medical expenditure, reduced treatment cost, improved rate of diagnosis, rise in adoption of favorable diagnostic programs, and favorable measures undertaken by governments of several nations are augmenting the market expansion.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/1856955/
 

Furthermore, spike in uptake of INSTI (Integrase Strand Transfer Inhibitor) based regimens, growing awareness regarding HIV treatment procedures, enhanced research and development pipeline, and introduction of new medications are expected to fuel the growth of global antiretroviral drugs market over the forecast period.
 

In terms of drug type, global antiretroviral drugs market is divided into protease inhibitors, NNRTI, combination drugs, NRTI, and multi-class drugs. The study claims that multi-class drugs segment is projected to showcase strong growth over the assessment period. 
 

As per the regional analysis, the industry is divided into Asia-Pacific, Europe, and North America. The country level bifurcation of the market includes South Africa, India, China, Japan, Italy, U.K, Germany, U.S., Canada, and France.
 

Among the regions, North America represents the largest regional share in global antiretroviral drugs market for the year 2017 owing to the high antiretroviral therapy (ART) coverage rate and increased accentuation towards branded prescription medications.
 

 Major players operating in global antiretroviral drugs market are Cipla Limited, Merck & Co., Inc., Johnson and Johnson, Boehringer-Ingelheim, AbbVie Inc., Bristol-Myer Squibb Co., Gilead Sciences Inc., and ViiV Healthcare.

Chat with us